Ventas, Inc. (VTR) is scheduled to report third-quarter 2024 results on Oct. 30, after market close. The quarterly results are likely to display year-over-year growth in revenues and normalized funds from operations (FFO) per share.Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.In the last reported quarter, this Chicago-based healthcare real estate investment trust (REIT) delivered a normalized FFO per share of 80 cents, beating the Zacks Consensus Estimate by 1.3%. The quarterly r ...

I've been holding on to this dividend-paying REIT, but there is a better option out there if you have new money to put to work. If you invest in dividend stocks, the one thing you will hate to see is a dividend cut. Unfortunately, they do happen and you'll likely deal with one in your portfolio sooner or later. How you choose to handle a dividend cutter can depend a great deal on the company's business and its future prospects. A good case study on both sides of this situation involves two dividend stocks I ...

Shares of Ventas (VTR) have gained 48.9% in the past six months compared with the industry's growth of 15.8%. This healthcare real estate investment trust (REIT) is well-positioned to gain from its diverse portfolio of healthcare real estate assets in the key markets of the United States and the U.K. An aging population and the rise in healthcare expenditure by senior citizens are likely to benefit the senior housing operating portfolio (SHOP). The outpatient medical portfolio is expected to gain from favor ...

Ventas (VTR) secured an agreement ("2024 Kindred Agreements") with Kindred Healthcare, LLC and its parent company, ScionHealth. This agreement is regarding 23 long-term acute care hospitals ("LTACs") whose lease term is scheduled to mature on April 30, 2025, under the existing master lease between Ventas and Kindred. This move enhances patient care facilities, strengthens the existing master lease and provide upside for Ventas. The company also obtains rights to additional revenue-sharing rent and warrants. ...

Ventas' (VTR) senior housing operating portfolio (SHOP) is likely to benefit from the aging population and the rising healthcare expenditures by senior citizens. Its outpatient medical and research portfolio is expected to gain from the favorable outpatient visit trends and the rising need for research related to life-saving vaccines and therapeutics. A healthy balance sheet position is likely to support its growth endeavors. However, dependence on few tenants and high interest rates add to its concern. Las ...

RiverNorthPhotography Introduction Ventas (NYSE:VTR) has significantly outperformed the Vanguard Real Estate ETF (VNQ) so far in 2024, delivering a ~22% total return against the ~10% gain for the benchmark ETF: ● Vist 8724 30 | w , wa on VTR vs VNQ (Seeking Alpha) While Q2 2024 results were excellent and the company increased its guidance, the REIT's valuation is also elevated, whether you look at the ~19x normalized FFO multiple or the ~5% market-implied cap rate. As such, considering the conservative capi ...

Shares of Ventas (VTR) have gained 34.1% in the past six months compared with the industry's growth of 7.9%. This Chicago-based healthcare real estate investment trust (REIT) is well-positioned to gain from its diverse portfolio of healthcare real estate assets in the key markets of the United States and the U.K. An aging population and the rise in healthcare expenditure by senior citizens are likely to benefit the senior housing operating portfolio (SHOP). The outpatient medical portfolio is expected to ga ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM____________TO____________ Commission file number: 1-10989 Ventas, Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 61-1055020 (State or Oth ...

Ventas, Inc. (NYSE:VTR) Q2 2024 Earnings Conference Call August 2, 2024 10:00 AM ET Company Participants Bill Grant - SVP, IR Debra Cafaro - Chairman & CEO Justin Hutchens - EVP, Senior Housing & CIO Robert Probst - EVP & CFO Peter Bulgarelli - Executive Vice President, Outpatient Medical & Research Conference Call Participants Nicholas Joseph - Citi Michael Carroll - RBC Capital Markets Joshua Dennerlein - Bank of America. Ronald Kamdem - Morgan Stanley James Kammert - Evercore ISI Juan Sanabria - BMO Omot ...

\ VENTAS® Earnings Presentation Second Quarter 2024 Non-GAAP Financial Measures & Cautionary Statements Non-GAAP Financial Measures This presentation of Ventas, Inc. (the "Company," "we," "us," "our" and similar terms) includes certain financial performance measures not defined by generally accepted accounting principles in the United States ("GAAP"), such as Nareit FFO, Normalized FFO, Net Operating Income ("NOI"), Same-Store Cash NOI, Same-Store Cash NOI Margin, Same-Store Cash NOI Growth and Net Debt to ...